The excess payments Medicare Advantage plans receive for higher risk scores may be more influenced by differences in coding practices rather than actual differences in disease burden between MA and ...
Medicare, the government-backed program for adults aged 65 and older and those with disabilities, only covers the use of ...
MedPage Today on MSN19h
Patients Struggle With Lack of Consistent Coverage for New Weight-Loss DrugsCoverage complications are not unusual in the U.S. healthcare system. But the challenge is magnified for these obesity ...
A groundbreaking national poll conducted on behalf of the Diabetes Patient Advocacy Coalition (DPAC) reveals overwhelming ...
Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
Supplies of high-demand obesity treatments are improving, but that doesn’t mean it's easier to get them. Many employers and ...
Zepbound may not be as widely known as its competitors, but the weight-loss drug may soon be more accessible than the rest.
Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...
United Health Group, the largest U.S. health insurer by enrollees, was under pressure after Sen. Chuck Grassley, chairman of the Senate Judiciary Committee, sent the conglomerate's chief executive, ...
Medicare Advantage (MA) plans, with fixed payments based on medical complexity, incentivize aggressive coding of comorbidities, potentially inflating costs for the federal government, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback